Study on the anti-inflammatory effects and mechanisms of gentisic acid based on the LPS-induced RAW264.7 cell inflammation model and the oxazolone-induced zebrafish inflammation model
Frontiers in Pharmacology · 26.06.2026 · 17
DOI: 10.3389/fphar.2026.1837686 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 26.06.2026. Verfasst von Yang Han und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Pekin Union Medical College Hospital, Beijing, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Gentisic acid (GA), a natural polyphenolic compound, possesses significant anti-inflammatory activity, but its molecular mechanism, particularly its association with the intestinal microbiota and specific signaling pathways, remains unclear.
Purpose
In this study, we aimed to clarify anti-inflammatory targets, pathways and mechanism of GA using network pharmacology, in vitro and in vivo experiments, and microbiome analysis. Materials and methods Network pharmacology was used to predict the anti-inflammatory targets and pathways of GA. Lipopolysaccharide (LPS)-induced RAW 264.7 cell models and oxazolone (OXA)-induced zebrafish models were established to evaluate the anti-inflammatory effects of GA. Quantitative real-time polymerase chain reaction (qRT-PCR), Western blotting, and 16S rDNA sequencing were used to detect changes in key genes, proteins, and intestinal microbiota, respectively. Results and discussion GA significantly attenuated LPS- and OXA-induced inflammation, reducing nitric oxide (NO) levels and inflammatory cytokines (IL-1β, TNF-α, and IL-6) in RAW 264.7 cells, along with IL-6 and IL-1β levels in zebrafish intestinal tissues. It was associated with the regulation of the IL-17 signaling pathway, reducing the abundance of Acinetobacter , Allorhizobium–Neorhizobium–Pararhizobium–Rhizobium , and Shewanella , which were positively correlated with key genes (IKKα, IKKβ, TRAF6, etc.) in the IL-17 pathway.
Conclusion
GA may exert anti-inflammatory effects potentially via correlatively regulating the composition of pathogenic intestinal bacteria to maintain microecological homeostasis and modulating the IL-17/NF-κB pathway. These correlative findings provide a valuable reference for the research and development of polyphenolic compounds.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, Pekin Union Medical College Hospital, Beijing, China.
- Institute of Feed Research of Chinese Academy of Agricultural Sciences, Beijing, China.
Zitieren
APA
Han, Y., Zhou, W., Zhang, Z., Zhang, Y., Liu, L., Zhao, J., Lyu, W., & Li, X. (2026). Study on the anti-inflammatory effects and mechanisms of gentisic acid based on the LPS-induced RAW264.7 cell inflammation model and the oxazolone-induced zebrafish inflammation model. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1837686
Vancouver
Han Y, Zhou W, Zhang Z, Zhang Y, Liu L, Zhao J, et al. Study on the anti-inflammatory effects and mechanisms of gentisic acid based on the LPS-induced RAW264.7 cell inflammation model and the oxazolone-induced zebrafish inflammation model. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1837686
BibTeX
@article{Han2026,
author = {Han, Yang and Zhou, Weiwei and Zhang, Zufeng and Zhang, Yuxin and Liu, Ling and Zhao, Jinhua and Lyu, Wei and Li, Xiumei},
title = {Study on the anti-inflammatory effects and mechanisms of gentisic acid based on the LPS-induced RAW264.7 cell inflammation model and the oxazolone-induced zebrafish inflammation model},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1837686}
}
EUVIMED